| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |